LABA/LAMA as first-line therapy for COPD: a summary of the evidence and guideline recommendations

M Miravitlles, T Kawayama, M Dreher - Journal of Clinical Medicine, 2022 - mdpi.com
Inhaled bronchodilators (alone or in combination) are the cornerstone of treatment for
symptomatic patients with COPD, either as initial/first-line treatment or for second …

Rational use of inhaled corticosteroids for the treatment of COPD

JK Quint, A Ariel, PJ Barnes - npj Primary Care Respiratory Medicine, 2023 - nature.com
Inhaled corticosteroids (ICS) are the mainstay of treatment for asthma, but their role in
chronic obstructive pulmonary disease (COPD) is debated. Recent randomised controlled …

Predictors of respiratory failure after thoracic surgery: a retrospective cohort study with comparison between lobar and sub-lobar resection

A Pezzuto, B Trabalza Marinucci… - Journal of …, 2022 - journals.sagepub.com
Objective Only approximately 15% of patients with lung cancer are suitable for surgery and
clinical postoperative outcomes vary. The aim of this study was to investigate variables …

Discovery, Multiparametric Optimization, and Solid-State Driven Identification of CHF-6550, a Novel Soft Dual Pharmacology Muscarinic Antagonist and β2 Agonist …

L Carzaniga, ID Linney, A Rizzi… - Journal of Medicinal …, 2024 - ACS Publications
Clinical guidelines for COPD and asthma recommend inhaled β-adrenergic agonists,
muscarinic antagonists, and, for frequent exacerbators, inhaled corticosteroids, with the …

[PDF][PDF] LABA/LAMA as First-Line Therapy for COPD: A Summary of the Evidence and Guideline Recommendations

M Miravitlles Fernández, T Kawayama, M Dreher - 2022 - scientiasalut.gencat.cat
Inhaled bronchodilators (alone or in combination) are the cornerstone of treatment for
symptomatic patients with COPD, either as initial/first-line treatment or for second …

[HTML][HTML] The role of tiotropium in COPD

CPD Login - medicalacademic.co.za
T he ABCD A ssessment tool has been updated in the recent guidelines–the number
provides information regarding airflow limitation (spirometry grading 1-4) and the letter …

[PDF][PDF] 慢性閉塞性肺疾患の第一選択治療としての

M Miravitlles - Therapeutic Research, 2023 - therres.jp
要 約吸入気管支拡張薬 (単剤または併用) は症状のある慢性閉塞性肺疾患 (COPD)
患者に対する基本的治療であり, 初期導入/第一選択治療として, または単剤療法にもかかわらず …

[引用][C] The role of tiotropium in COPD

I Mohamed